• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病的遗传学、转录组学和蛋白质组学

Genetics, transcriptomics, and proteomics of Alzheimer's disease.

作者信息

Papassotiropoulos Andreas, Fountoulakis Michael, Dunckley Travis, Stephan Dietrich A, Reiman Eric M

机构信息

Division of Psychiatry Research, University of Zurich, Zurich, Switzerland.

出版信息

J Clin Psychiatry. 2006 Apr;67(4):652-70. doi: 10.4088/jcp.v67n0418.

DOI:10.4088/jcp.v67n0418
PMID:16669732
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2259384/
Abstract

OBJECTIVE

To provide an updated overview of the methods used in genetic, transcriptomic, and proteomic studies in Alzheimer's disease and to demonstrate the importance of those methods for the improvement of the current diagnostic and therapeutic possibilities.

DATA SOURCES

MEDLINE-based search of 233 peer-reviewed articles published between 1975 and 2006.

DATA SYNTHESIS

Alzheimer's disease is a genetically heterogeneous disorder. Rare mutations in the amyloid precursor protein, presenilin 1, and presenilin 2 genes have shown the importance of the amyloid metabolism for its development. In addition, converging evidence from population-based genetic studies, gene expression studies, and protein profile studies in the brain and in the cerebrospinal fluid suggest the existence of several pathogenetic pathways such as amyloid precursor protein processing, beta-amyloid degradation, tau phosphorylation, proteolysis, protein misfolding, neuroinflammation, oxidative stress, and lipid metabolism.

CONCLUSIONS

The development of high-throughput genotyping methods and of elaborated statistical analyses will contribute to the identification of genetic risk profiles related to the development and course of this devastating disease. The integration of knowledge derived from genetic, transcriptomic, and proteomic studies will greatly advance our understanding of the causes of Alzheimer's disease, improve our capability of establishing an early diagnosis, help define disease subgroups, and ultimately help to pave the road toward improved and tailored treatments.

摘要

目的

提供阿尔茨海默病遗传、转录组和蛋白质组学研究中所用方法的最新综述,并证明这些方法对于改善当前诊断和治疗可能性的重要性。

数据来源

基于MEDLINE检索1975年至2006年间发表的233篇同行评议文章。

数据综合

阿尔茨海默病是一种遗传异质性疾病。淀粉样前体蛋白、早老素1和早老素2基因中的罕见突变已表明淀粉样代谢对其发展的重要性。此外,基于人群的遗传研究、基因表达研究以及大脑和脑脊液中的蛋白质谱研究得出的一致证据表明存在多种致病途径,如淀粉样前体蛋白加工、β-淀粉样蛋白降解、tau蛋白磷酸化、蛋白水解、蛋白质错误折叠、神经炎症、氧化应激和脂质代谢。

结论

高通量基因分型方法和精细统计分析的发展将有助于识别与这种毁灭性疾病的发展和进程相关的遗传风险概况。整合来自遗传、转录组和蛋白质组学研究的知识将极大地推进我们对阿尔茨海默病病因的理解,提高我们早期诊断的能力,帮助定义疾病亚组,并最终有助于为改进和个性化治疗铺平道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2305/2259384/411907b189ce/nihms40846f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2305/2259384/b29fb3111b90/nihms40846f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2305/2259384/bd620b1278a8/nihms40846f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2305/2259384/411907b189ce/nihms40846f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2305/2259384/b29fb3111b90/nihms40846f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2305/2259384/bd620b1278a8/nihms40846f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2305/2259384/411907b189ce/nihms40846f3.jpg

相似文献

1
Genetics, transcriptomics, and proteomics of Alzheimer's disease.阿尔茨海默病的遗传学、转录组学和蛋白质组学
J Clin Psychiatry. 2006 Apr;67(4):652-70. doi: 10.4088/jcp.v67n0418.
2
Exploring the Role of Aggregated Proteomes in the Pathogenesis of Alzheimer's Disease.探讨聚集蛋白组在阿尔茨海默病发病机制中的作用。
Curr Protein Pept Sci. 2020;21(12):1164-1173. doi: 10.2174/1389203721666200921152246.
3
Piecing together Alzheimer's.拼凑阿尔茨海默病
Sci Am. 2000 Dec;283(6):76-83. doi: 10.1038/scientificamerican1200-76.
4
Alzheimer's disease: genotypes, phenotypes, and treatments.阿尔茨海默病:基因型、表型与治疗方法
Science. 1997 Jan 31;275(5300):630-1. doi: 10.1126/science.275.5300.630.
5
Genes and mechanisms involved in beta-amyloid generation and Alzheimer's disease.参与β-淀粉样蛋白生成及阿尔茨海默病的基因与机制。
Eur Arch Psychiatry Clin Neurosci. 1999;249(6):266-70. doi: 10.1007/s004060050098.
6
The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors.不同早老素1和早老素2突变对家族性阿尔茨海默病大脑中淀粉样蛋白沉积、神经原纤维变化及神经元丢失的影响:其他表型修饰因子的证据
Brain. 1999 Sep;122 ( Pt 9):1709-19. doi: 10.1093/brain/122.9.1709.
7
The molecular bases of Alzheimer's disease and other neurodegenerative disorders.阿尔茨海默病及其他神经退行性疾病的分子基础。
Arch Med Res. 2001 Sep-Oct;32(5):367-81. doi: 10.1016/s0188-4409(01)00316-2.
8
Amyloid beta-protein and the genetics of Alzheimer's disease.淀粉样β蛋白与阿尔茨海默病的遗传学
J Biol Chem. 1996 Aug 2;271(31):18295-8. doi: 10.1074/jbc.271.31.18295.
9
Genetics of Alzheimer's disease.阿尔茨海默病的遗传学
Essays Biochem. 1998;33:117-31. doi: 10.1042/bse0330117.
10
Molecular genetics of Alzheimer's disease and aging.阿尔茨海默病与衰老的分子遗传学
Methods Find Exp Clin Pharmacol. 2005 Jul;27 Suppl A:1-573.

引用本文的文献

1
IDCC 3451 alleviates cognitive and behavioral functions by reshaping the gut microbiome and regulating intestinal barrier integrity in chronic stress animal models.在慢性应激动物模型中,IDCC 3451通过重塑肠道微生物群和调节肠道屏障完整性来缓解认知和行为功能。
Curr Res Food Sci. 2025 Apr 14;10:101051. doi: 10.1016/j.crfs.2025.101051. eCollection 2025.
2
Exploratory Longitudinal Study of Ocular Structural and Visual Functional Changes in Subjects at High Genetic Risk of Developing Alzheimer's Disease.阿尔茨海默病高遗传风险受试者眼部结构和视觉功能变化的探索性纵向研究。
Biomedicines. 2023 Jul 18;11(7):2024. doi: 10.3390/biomedicines11072024.
3

本文引用的文献

1
Gene expression correlates of neurofibrillary tangles in Alzheimer's disease.阿尔茨海默病中神经原纤维缠结的基因表达相关性
Neurobiol Aging. 2006 Oct;27(10):1359-71. doi: 10.1016/j.neurobiolaging.2005.08.013. Epub 2005 Oct 19.
2
Functional Genomics meets neurodegenerative disorders. Part II: application and data integration.功能基因组学与神经退行性疾病。第二部分:应用与数据整合。
Prog Neurobiol. 2005 Jun;76(3):169-88. doi: 10.1016/j.pneurobio.2005.07.002.
3
Functional Genomics meets neurodegenerative disorders Part I: transcriptomic and proteomic technology.
Translatome analysis reveals microglia and astrocytes to be distinct regulators of inflammation in the hyperacute and acute phases after stroke.
转录组分析揭示小胶质细胞和星形胶质细胞在中风后超急性期和急性期炎症中是不同的调节者。
Glia. 2023 Aug;71(8):1960-1984. doi: 10.1002/glia.24377. Epub 2023 Apr 17.
4
Screening for Genetic Mutations Associated with Early-Onset Alzheimer's Disease in Han Chinese.汉族人群早发性阿尔茨海默病相关基因突变的筛查
Curr Alzheimer Res. 2022;19(10):724-733. doi: 10.2174/1567205020666221028112915.
5
Willin/FRMD6: A Multi-Functional Neuronal Protein Associated with Alzheimer's Disease.Willin/FRMD6:一种与阿尔茨海默病相关的多功能神经元蛋白。
Cells. 2021 Nov 4;10(11):3024. doi: 10.3390/cells10113024.
6
Utility of Animal Models to Understand Human Alzheimer's Disease, Using the Mastermind Research Approach to Avoid Unnecessary Further Sacrifices of Animals.利用“大师脑”研究方法理解人类阿尔茨海默病的动物模型效用,避免不必要地牺牲更多动物。
Int J Mol Sci. 2020 Apr 30;21(9):3158. doi: 10.3390/ijms21093158.
7
Plasma Biomarkers: Potent Screeners of Alzheimer's Disease.血浆生物标志物:阿尔茨海默病的有效筛查指标。
Am J Alzheimers Dis Other Demen. 2019 Aug;34(5):290-301. doi: 10.1177/1533317519848239. Epub 2019 May 9.
8
The Potential of 'Omics to Link Lipid Metabolism and Genetic and Comorbidity Risk Factors of Alzheimer's Disease in African Americans.“组学”在非裔美国人的脂质代谢与阿尔茨海默病遗传和共病风险因素关联中的作用。
Adv Exp Med Biol. 2019;1118:1-28. doi: 10.1007/978-3-030-05542-4_1.
9
Inferring disease risk genes from sequencing data in multiplex pedigrees through sharing of rare variants.通过共享罕见变异从多重家系的测序数据中推断疾病风险基因。
Genet Epidemiol. 2019 Feb;43(1):37-49. doi: 10.1002/gepi.22155. Epub 2018 Sep 24.
10
Extracellular matrix proteomics in schizophrenia and Alzheimer's disease.精神分裂症和阿尔茨海默病的细胞外基质蛋白质组学。
Anal Bioanal Chem. 2017 Jan;409(2):379-394. doi: 10.1007/s00216-016-9900-6. Epub 2016 Sep 6.
功能基因组学与神经退行性疾病 第一部分:转录组学和蛋白质组学技术
Prog Neurobiol. 2005 Jun;76(3):153-68. doi: 10.1016/j.pneurobio.2005.07.001.
4
APOA1 polymorphism influences risk for early-onset nonfamiliar AD.载脂蛋白A1基因多态性影响早发性散发性阿尔茨海默病的发病风险。
Ann Neurol. 2005 Sep;58(3):436-41. doi: 10.1002/ana.20593.
5
A cluster of cholesterol-related genes confers susceptibility for Alzheimer's disease.一组与胆固醇相关的基因赋予了患阿尔茨海默病的易感性。
J Clin Psychiatry. 2005 Jul;66(7):940-7.
6
Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism.载脂蛋白E ε4基因剂量与区域代谢减退的脑成像测量之间的相关性。
Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8299-302. doi: 10.1073/pnas.0500579102. Epub 2005 Jun 2.
7
Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease.阿尔茨海默病小鼠模型中皮质基因表达的比较分析。
Neurobiol Aging. 2006 Mar;27(3):377-86. doi: 10.1016/j.neurobiolaging.2005.02.010. Epub 2005 May 31.
8
Gene expression profile of amyloid beta protein-injected mouse model for Alzheimer disease.
Acta Pharmacol Sin. 2005 Jun;26(6):666-72. doi: 10.1111/j.1745-7254.2005.00129.x.
9
Complement factor H polymorphism in age-related macular degeneration.年龄相关性黄斑变性中的补体因子H多态性
Science. 2005 Apr 15;308(5720):385-9. doi: 10.1126/science.1109557. Epub 2005 Mar 10.
10
Family-based association between Alzheimer's disease and variants in UBQLN1.阿尔茨海默病与泛素样蛋白1(UBQLN1)变体之间基于家族的关联。
N Engl J Med. 2005 Mar 3;352(9):884-94. doi: 10.1056/NEJMoa042765.